Melanomas, metastases, and survival.
作者信息
Rennie I
出版信息
Br J Ophthalmol. 1993 Nov;77(11):685-6. doi: 10.1136/bjo.77.11.685.
Abstract
摘要
相似文献
1
Melanomas, metastases, and survival.黑色素瘤、转移及生存情况。
Br J Ophthalmol. 1993 Nov;77(11):685-6. doi: 10.1136/bjo.77.11.685.
2
Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival.眼部黑色素瘤转移的监测性检测及其对患者生存的影响。
Am J Ophthalmol. 2011 Jul;152(1):5-9.e1. doi: 10.1016/j.ajo.2011.03.004. Epub 2011 May 20.
3
[Prognostic factors for uveal melanoma].[葡萄膜黑色素瘤的预后因素]
Vestn Oftalmol. 2015 Jan-Feb;131(1):90-95. doi: 10.17116/oftalma2015131190-94.
4
Long-term survival in a patient with uveal melanoma and liver metastasis.一名患有葡萄膜黑色素瘤和肝转移的患者的长期生存情况。
Arch Ophthalmol. 2004 Feb;122(2):285-7. doi: 10.1001/archopht.122.2.285.
5
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.黏膜、葡萄膜、肢端、非肢端皮肤及原发灶不明黑色素瘤自首次转移起的预后
Oncologist. 2016 Jul;21(7):848-54. doi: 10.1634/theoncologist.2015-0522. Epub 2016 Jun 10.
6
Survival after primary enucleation of largest uveal melanomas.最大脉络膜黑色素瘤一期眼球摘除术后的生存率。
Acta Ophthalmol Scand. 2005 Jun;83(3):398; 398-9. doi: 10.1111/j.1600-0420.2005.0433c.x.
7
MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.基质金属蛋白酶-9主要在上皮样而非梭形细胞葡萄膜黑色素瘤中表达。
J Pathol. 2001 Jun;194(2):201-6. doi: 10.1002/1096-9896(200106)194:2<201::AID-PATH840>3.0.CO;2-O.
8
Optic nerve invasion of uveal melanoma: clinical characteristics and metastatic pattern.葡萄膜黑色素瘤的视神经侵犯：临床特征与转移模式
Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3268-75. doi: 10.1167/iovs.05-1435.
9
Nucleolar size in choroidal and ciliary body melanomas and corresponding hepatic metastases.脉络膜和睫状体黑色素瘤及其相应的肝转移瘤中的核仁大小。
Acta Ophthalmol. 2010 Jun;88(4):458-62. doi: 10.1111/j.1755-3768.2009.01556.x. Epub 2009 Jun 22.
10
Mortality from uveal melanoma treated by enucleation --a 16-year survey in Taiwan.眼球摘除术治疗葡萄膜黑色素瘤的死亡率——台湾地区的16年调查
Acta Ophthalmol. 2013 Nov;91(7):e583-4. doi: 10.1111/aos.12168. Epub 2013 Jun 13.
引用本文的文献
1
Mortality after deferral of treatment or no treatment for choroidal melanoma.脉络膜黑色素瘤延迟治疗或不治疗的死亡率。
Indian J Ophthalmol. 2018 Oct;66(10):1395-1400. doi: 10.4103/ijo.IJO_1499_18.
本文引用的文献
1
A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma.
Arch Ophthalmol. 1983 Dec;101(12):1894-9. doi: 10.1001/archopht.1983.01040020896012.
2
Malignent melanomas of the human uvea. Recent follow-up of cases in Denmark, 1943-1952.人类葡萄膜恶性黑色素瘤。丹麦1943 - 1952年病例的近期随访
Acta Ophthalmol (Copenh). 1970;48(6):1113-28.
3
Metastatic patterns of choroidal melanoma.脉络膜黑色素瘤的转移模式。
Cancer. 1974 Oct;34(4):1001-4. doi: 10.1002/1097-0142(197410)34:4<1001::aid-cncr2820340406>3.0.co;2-z.
4
Nonrandom chromosomal abnormalities in primary uveal melanoma.
J Natl Cancer Inst. 1990 Nov 21;82(22):1765-9. doi: 10.1093/jnci/82.22.1765.
5
Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8.6例后葡萄膜黑色素瘤的细胞遗传学发现：3号、6号和8号染色体受累
Genes Chromosomes Cancer. 1990 Sep;2(3):205-9. doi: 10.1002/gcc.2870020307.
6
Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.人类癌症转移生物学中的关键因素：第28届G.H.A. 克劳斯纪念奖讲座
Cancer Res. 1990 Oct 1;50(19):6130-8.
7
A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988.脉络膜黑色素瘤死亡率综述。II. 1966年至1988年眼球摘除术后5年死亡率的荟萃分析。
Arch Ophthalmol. 1992 Feb;110(2):245-50. doi: 10.1001/archopht.1992.01080140101036.
8
Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma.与后葡萄膜黑色素瘤相关的3号、6号和8号染色体的非随机异常。
Genes Chromosomes Cancer. 1992 Oct;5(3):197-200. doi: 10.1002/gcc.2870050304.
9
Quantitation of cell shedding into efferent blood of mammary adenocarcinoma.乳腺腺癌向输出血流中细胞脱落的定量分析。
Cancer Res. 1975 Mar;35(3):512-6.
10
Prognostic factors in choroidal and ciliary body melanomas.
Arch Ophthalmol. 1977 Jan;95(1):63-9. doi: 10.1001/archopht.1977.04450010065005.
Zotero 插件